240
Participants
Start Date
September 9, 2025
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2029
Conventional external beam radiation therapy dose (EBRT)
Participants will undergo 8 Gray in 1 fraction of EBRT. Questionnaires (brief pain inventory, COST-FACIT, EuroQol EQ-5D) will be administered at baseline, and again at 3,6,9,12 month follow-up.
Spine radiosurgery/stereotactic body radiation therapy standard dose
Participants will undergo 24 Gray in 2 fractions of SBRT. Questionnaires (brief pain inventory, COST-FACIT, EuroQol EQ-5D) will be administered at baseline, and again at 3,6,9,12 month follow-up.
Spine radiosurgery/stereotactic body radiation therapy high dose
Participants will undergo 19 Gray in 1 fraction of SBRT. Questionnaires (brief pain inventory, COST-FACIT, EuroQol EQ-5D) will be administered at baseline, and again at 3,6,9,12 month follow-up.
ACTIVE_NOT_RECRUITING
Johns Hopkins University Hospitals, Baltimore
RECRUITING
OU Health Stephenson Cancer Center, Oklahoma City
University of Oklahoma
OTHER